Correcting and Updating-Previous post incorrectly mentioned that Arrayit Corporation shipped a $100 TissueMax. The corrected and updated version is below
Listonstreetpulse.com announces that Arrayit Corporation (OTC: ARYC), a developer, manufacturer and marketer of proprietary life science technologies and consumables for disease prevention, treatment and cure, has shipped a $100,000 TissueMax® Automated Tissue Microarrayer to the University of Miami in Miami, Florida, USA. A life sciences instrument, TissueMax® speeds the preparation of tissue microarrays, which are medical devices that facilitate the analysis of tumor samples by enabling scientists and doctors to rapidly identify genes and proteins inappropriately expressed in cancer and human conditions.
The instrument also enables clinicians to examine tissue samples for immunological compatibility to better match donors and recipients for kidney, pancreas, liver, heart and lung transplantation. Apart from TissueMax®, ARYC’s other market leading microarray manufacturing instruments include the SpotBot® and NanoPrint™ product lines. ARYC expects to book the revenue and earnings from the latest TissueMax® order in the third and the fourth quarter of this year.
To read more about ARYC and subscribe to a monthly update, CEO interview etc, please click here – http://www.listonstreetpulse.com/tag/ARYC/
About Arrayit Corporation
Arrayit Corporation is a Sunnyvale, California-based company leading and empowering the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. The company’s innovative products and services help scientists and clinicians explore the human genome as well as the genomes of plants and animals. Arrayit’s products are used by every major research center in the world.
About Liston Street Pulse
Liston Street Pulse is a leading provider of financial research. The company has significant expertise in U.S. listed small cap and micro-cap stocks. Over the years, Liston Street Pulse’s original and unbiased analysis has helped the investor community immensely.
